SEC Filing Details

Document Details

Filing Date
Oct 22, 2018
Document Date
Oct 22, 2018
Form Description
Filing by person(s) reporting owned shares of common stock in a public company >5%
Filing Group
Other
Company
Allogene Therapeutics
Issuer
Allogene Therapeutics, Inc.